What does REAUTHORIZATION OF ACCELERATING ACCESS TO CRITICAL THERAPIES of Accelerating Access to Critical Therapies for ALS Reauthorization Act of 2026 do?

This section reauthorizes the Accelerating Access to Critical Therapies for ALS Act The reauthorization extends until 2031

What does IMPROVEMENTS TO PROGRAM FOR GRANTS FOR RESEARCH ON THERAPIES of Accelerating Access to Critical Therapies for ALS Reauthorization Act of 2026 do?

This section amends the Accelerating Access to Critical Therapies for ALS Act. It modifies Section 2(b) to require the Secretary to assess the status of clinical trials, including patient enrollment data, when reviewing grant renewal applications for investigational drugs. The Secretary is authorized to request interim clinical trial data from the manufacturer of the investigational drug. It modifies Section 2(e) to clarify the definition of 'phase 3' clinical trial, including combined phase 2/3 trials and planned phase 3 trials that haven't yet enrolled participants.

What does REPORT ON ALS AND OTHER RARE NEURODEGENERATIVE DISEASE ACTION of Accelerating Access to Critical Therapies for ALS Reauthorization Act of 2026 do?

This section amends the Accelerating Access to Critical Therapies for ALS Act The Commissioner of Food and Drugs must publish a report within one year of enactment The report includes an updated action plan for ALS and other rare neurodegenerative diseases The plan describes actions, resources, and approaches for implementation The report also evaluates the 2022 Action Plan's implementation and effects

Back to bills

Accelerating Access to Critical Therapies for ALS Reauthorization Act of 2026

Q: What does Preamble of Accelerating Access to Critical Therapies for ALS Reauthorization Act of 2026 do?

This bill amends the Accelerating Access to Critical Therapies for ALS Act. The bill reauthorizes the provisions of the Accelerating Access to Critical Therapies for ALS Act through fiscal year 2031. The bill includes provisions for other purposes, though these are not specified in the preamble.

Q: What does SHORT TITLE. of Accelerating Access to Critical Therapies for ALS Reauthorization Act of 2026 do?

This bill is formally titled the Accelerating Access to Critical Therapies for ALS Reauthorization Act of 2026.

Q: What does GAO REPORT. of Accelerating Access to Critical Therapies for ALS Reauthorization Act of 2026 do?

This section amends Section 6 of the Accelerating Access to Critical Therapies for ALS Act (Public Law 117-79). The amendment changes the timeframe for a report from '4 years after the date of the enactment of this Act' to '5 years after the date of enactment of the Accelerating Access to Critical Therapies for ALS Reauthorization Act of 2026'. The amendment also inserts a clause specifying that the report should contain information 'with respect to the 10-year period starting on the date of enactment of this Act'.

Last updated: 6/17/2026 · Introduced: 4/30/2026

Author: Lisa Murkowski (R-AK)

TL;DR (AI)

This bill extends the Accelerating Access to Critical Therapies for ALS Act through fiscal year 2031.
It requires the Secretary to consider clinical trial status and enrollment data when reviewing grant renewal applications for investigational ALS drugs and allows for requests of interim clinical trial data.
The bill mandates a report from the FDA within one year of enactment, evaluating and updating the action plan for ALS and other rare neurodegenerative diseases.

119th Congressin committeeHR. 8205(In Committee)Official page

Verified Votes

No verified votes yet.

Community Votes

No community votes yet. Be the first!

Voting as guest · Sign in for verified votes

Other Sections

Includes provisions on preamble, short title., and 4 more.

6 sections

Click "Show details" to explore individual sections. Use the community vote above or visit All Sections to vote per section.

Read official text

Want the full experience?

Create a free account to cast verified votes on each section, get a personalized summary, and track your voting history.

Create Free Account